Showing results (1-10 of 23,303) with videos related to
Sort By:
Pageof 2,331
Current Opinion in Oncology|July 19, 2021
Targeting SUMOylation in cancerLi Du, Wei Liu, Steven T RosenJournal of Molecular Biology|January 21, 2023
Mechanism of SUMOylation-Mediated Regulation of Type I IFN ExpressionLi Du, Wei Liu, Steven T Rosen, et al.Cancer Gene Therapy|March 26, 2022
SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomideLi Du, Wei Liu, Flavia Pichiorri, et al.Journal of Experimental & Clinical Cancer Research : CR|January 5, 2022
SUMOylation inhibition enhances dexamethasone sensitivity in multiple myelomaLi Du, Wei Liu, Grace Aldana-Masangkay, et al.Cancer Research|August 21, 2020
SUMOylation of E2F1 Regulates Expression of EZH2Li Du, Marwan G Fakih, Steven T Rosen, et al.Hematological Oncology|January 1, 2026
International Cost-Effectiveness Analysis of Nivolumab Versus Brentuximab Vedotin for Patients With Advanced-Stage Classic Hodgkin's LymphomaYouwen Zhu, Kun Liu, Steven T Rosen, et al.Eclinicalmedicine|July 21, 2025
Treatment-related adverse events of chimeric antigen receptor-T therapies for cancers in clinical trials: a systematic review and meta-analysisYouwen Zhu, Kun Liu, Steven T Rosen, et al.The Lancet. Oncology|June 12, 2026
Treatment-related adverse events of CD3-based T cell-engaging bispecific antibodies in patients with cancer: a meta-analysis of clinical trialsYouwen Zhu, Kun Liu, Steven T Rosen, et al.Current Opinion in Oncology|January 1, 2005
Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updatesOlga Frankfurt, Steven T RosenOncology (Williston Park, N.Y.)|March 17, 2015
Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 1Tanya Siddiqi, Steven T RosenPageof 2,331